Neil Brewis serves as Executive at F-star Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Neil Brewis has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 8, 2023 involved selling 9,375 shares valued at $66.8K.
Neil Brewis currently holds 9,375 shares of F-star Therapeutics, Inc. (FSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Brewis has been a net neutral trader of FSTX stock. They have purchased $0 and sold $0 worth of shares.
Neil Brewis's most recent insider trade was on Mar 8, 2023, when they sold 9,375 shares at $7.12 per share.
Get notified when new Form 4 filings are submitted
| $7.12 |
| Discretionary |
| Jul 29, 2022 | FSTX | $8.4K | Option Exercise | 76,619 | $0.11 | Discretionary |
| Feb 1, 2021 | FSTX | $0 | Award | 18,000 | $N/A | Discretionary |
| Nov 20, 2020 | FSTX | $0 | Award | 19,844 | $N/A | Discretionary |